Valeritas Holdings (Valeritas Holdings) Gross Profit : $14.22 Mil (TTM As of Sep. 2019)

View and export this data going back to 2015. Start your Free Trial

What is Valeritas Holdings Gross Profit?

Valeritas Holdings's gross profit for the three months ended in Sep. 2019 was $4.20 Mil. Valeritas Holdings's gross profit for the trailing twelve months (TTM) ended in Sep. 2019 was $14.22 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Valeritas Holdings's gross profit for the three months ended in Sep. 2019 was $4.20 Mil. Valeritas Holdings's Revenue for the three months ended in Sep. 2019 was $8.46 Mil. Therefore, Valeritas Holdings's Gross Margin % for the quarter that ended in Sep. 2019 was 49.62%.

Valeritas Holdings had a gross margin of 49.62% for the quarter that ended in Sep. 2019 => Durable competitive advantage

Valeritas Holdings Gross Profit Historical Data

The historical data trend for Valeritas Holdings's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeritas Holdings Gross Profit Chart

Valeritas Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Gross Profit

3.86

6.94

8.17

12.42

Valeritas Holdings Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Gross Profit	Get a 7-Day Free Trial															3.18	3.26	3.05	3.72	4.20

Competitive Comparison of Valeritas Holdings's Gross Profit

For the Medical Instruments & Supplies subindustry, Valeritas Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valeritas Holdings's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Valeritas Holdings's Gross Profit distribution charts can be found below:

* The bar in red indicates where Valeritas Holdings's Gross Profit falls into.

Valeritas Holdings Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Valeritas Holdings's Gross Profit for the fiscal year that ended in Dec. 2018 is calculated as

Gross Profit (A: Dec. 2018 )	=	Revenue	-	Cost of Goods Sold
	=	26.398	-	13.974
	=	12.42

Valeritas Holdings's Gross Profit for the quarter that ended in Sep. 2019 is calculated as

Gross Profit (Q: Sep. 2019 )	=	Revenue	-	Cost of Goods Sold
	=	8.463	-	4.264
	=	4.20

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.22 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Valeritas Holdings's Gross Margin % for the quarter that ended in Sep. 2019 is calculated as

Gross Margin % (Q: Sep. 2019 )	=	Gross Profit (Q: Sep. 2019 )	/	Revenue (Q: Sep. 2019 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	4.20	/	8.463
	=	49.62 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Valeritas Holdings (OTCPK:VLRXQ) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Valeritas Holdings had a gross margin of 49.62% for the quarter that ended in Sep. 2019 => Durable competitive advantage

Valeritas Holdings Gross Profit Related Terms

Thank you for viewing the detailed overview of Valeritas Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Valeritas Holdings (Valeritas Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Valeritas Holdings Inc (OTCPK:VLRXQ) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

N/A

Address

750 Route 202 South, Suite 600, Bridgewater, NJ, USA, 08807

Website

https://www.valeritas.com

Valeritas Holdings Inc is a commercial-stage medical technology company. It is engaged in the business of improving health and simplifying life for diabetic patients by developing and commercializing innovative technologies. The company designed its first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, that supports the patients with Type 2 diabetes who need insulin to achieve and maintain their target blood glucose goals. V-Go is a small easy-to-use disposable insulin delivery device that a patient wears on his or her skin every 24 hours. It commenced commercial sales of V-Go first in the US and has a sales footprint spread across the country. The company primarily generates its revenues in the United States.

Executives

Armistice Capital, Llc	10 percent owner	510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
Armistice Capital Master Fund Ltd.	10 percent owner	C/O ARMISTICE CAPITAL, LLC, 510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
Steven Boyd	10 percent owner	510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
Cr Group L.p.	10 percent owner	1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Joseph M Mandato	director	765 MARKET STREET SUITE 290, SAN FRANCISCO CA 941003
Peter Devlin	director	65 WALNUT AVENUE, ANDOVER MA 01810
Brian K Roberts	director	DIGITAS INC.,, 800 BOYLSTON STREET, BOSTON MA 02199
Erick Lucera	officer: See Remarks	138 THISTLE ROAD, NORTH ANDOVER MA 08145
Geoffrey Jenkins	officer: See Remarks	C/O UV SOLUTIONS, 15 GLENBROOK RD, WELLESLEY HILLS MA 02461